Effects of Cell Metabolites on Methotrexate Toxicity
Author Information
Author(s): J.M. Hughes, A. deFazio, M.H.N. Tattersall
Primary Institution: University of Sydney
Hypothesis
Can metabolites from dying cells prevent methotrexate cytotoxicity in lymphocytes?
Conclusion
Metabolites released from dying cells can protect surviving lymphocytes from the cytotoxic effects of methotrexate.
Supporting Evidence
- Metabolites like thymidine and hypoxanthine were found to protect lymphocytes from methotrexate toxicity.
- High initial cell densities affected the cytotoxicity of methotrexate.
- Cell growth was observed even in the presence of methotrexate when certain conditions were met.
Takeaway
When some cells die, they release substances that can help other cells survive even when a drug that usually kills them is present.
Methodology
A lymphocyte clonal assay was used to study the effects of methotrexate on cell survival, with various culture conditions and drug concentrations tested.
Limitations
The study may not account for all factors influencing drug resistance in different cell types.
Participant Demographics
Blood donations from 16 normal donors were used.
Want to read the original?
Access the complete publication on the publisher's website